DexCom EBITDA 2010-2024 | DXCM

DexCom annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • DexCom EBITDA for the quarter ending March 31, 2024 was $0.154B, a 72.97% increase year-over-year.
  • DexCom EBITDA for the twelve months ending March 31, 2024 was $0.849B, a 52.12% increase year-over-year.
  • DexCom 2023 annual EBITDA was $0.784B, a 43.25% increase from 2022.
  • DexCom 2022 annual EBITDA was $0.547B, a 48.75% increase from 2021.
  • DexCom 2021 annual EBITDA was $0.368B, a 0.33% increase from 2020.
DexCom Annual EBITDA
(Millions of US $)
2023 $784
2022 $547
2021 $368
2020 $367
2019 $191
2018 $-157
2017 $-26
2016 $-49
2015 $-46
2014 $-13
2013 $-21
2012 $-48
2011 $-40
2010 $-42
2009 $-42
DexCom Quarterly EBITDA
(Millions of US $)
2024-03-31 $154
2023-12-31 $269
2023-09-30 $254
2023-06-30 $172
2023-03-31 $89
2022-12-31 $162
2022-09-30 $187
2022-06-30 $121
2022-03-31 $78
2021-12-31 $33
2021-09-30 $144
2021-06-30 $125
2021-03-31 $67
2020-12-31 $124
2020-09-30 $113
2020-06-30 $83
2020-03-31 $47
2019-12-31 $116
2019-09-30 $69
2019-06-30 $11
2019-03-31 $-5
2018-12-31 $-156
2018-09-30 $22
2018-06-30 $2
2018-03-31 $-25
2017-12-31 $16
2017-09-30 $4
2017-06-30 $-10
2017-03-31 $-37
2016-12-31 $-3
2016-09-30 $-14
2016-06-30 $-16
2016-03-31 $-16
2015-12-31 $4
2015-09-30 $-40
2015-06-30 $-1
2015-03-31 $-10
2014-12-31 $4
2014-09-30 $-3
2014-06-30 $-4
2014-03-31 $-10
2013-12-31 $-0
2013-09-30 $-4
2013-06-30 $-8
2013-03-31 $-9
2012-12-31 $-6
2012-09-30 $-15
2012-06-30 $-13
2012-03-31 $-14
2011-12-31 $-11
2011-09-30 $-12
2011-06-30 $-6
2011-03-31 $-11
2010-12-31 $-9
2010-09-30 $-12
2010-06-30 $-10
2010-03-31 $-10
2009-12-31 $-9
2009-09-30 $-11
2009-06-30 $-12
2009-03-31 $-10
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $51.973B $3.622B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $226.743B 27.48
Intuitive Surgical (ISRG) United States $141.891B 85.48
Edwards Lifesciences (EW) United States $54.101B 35.21
IDEXX Laboratories (IDXX) United States $43.777B 51.31
Alcon (ALC) Switzerland $43.442B 31.13
IQVIA Holdings (IQV) United States $41.922B 24.32
STERIS (STE) Ireland $22.999B 26.88
Waters (WAT) United States $21.000B 30.86
SONOVA HOLDING (SONVY) Switzerland $18.908B 0.00
Hologic (HOLX) United States $17.468B 19.54
Fresenius Medical Care AG KGaA (FMS) Germany $12.869B 15.02
ShockWave Medical (SWAV) United States $12.384B 77.07
Sysmex ADR (SSMXY) Japan $11.134B 34.91
Teleflex (TFX) United States $10.108B 15.73
Globus Medical (GMED) United States $8.970B 26.29
Penumbra (PEN) United States $7.809B 88.74
Masimo (MASI) United States $6.723B 38.73
Glaukos (GKOS) United States $5.504B 0.00
TransMedics (TMDX) United States $4.566B 433.19
Integer Holdings (ITGR) United States $4.029B 24.34
PROCEPT BioRobotics (PRCT) United States $3.533B 0.00
LivaNova (LIVN) United Kingdom $3.318B 19.70
Tandem Diabetes Care (TNDM) United States $3.051B 0.00
Elekta AB (EKTAY) Sweden $2.973B 20.40
Inari Medical (NARI) United States $2.682B 0.00
Nihon Kohden (NHNKY) Japan $2.474B 20.92
RxSight (RXST) United States $2.317B 0.00
Integra LifeSciences Holdings (IART) United States $2.126B 9.27
Veracyte (VCYT) United States $1.705B 0.00
Alphatec Holdings (ATEC) United States $1.543B 0.00
Artivion (AORT) United States $0.993B 95.24
AVANOS MEDICAL, INC (AVNS) United States $0.933B 18.14
OPKO Health (OPK) United States $0.920B 0.00
Silk Road Medical (SILK) United States $0.897B 0.00
OrthoPediatrics (KIDS) United States $0.775B 0.00
Mesa Laboratories (MLAB) United States $0.656B 22.26
Paragon 28 (FNA) United States $0.621B 0.00
SiBone (SIBN) United States $0.593B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.567B 0.00
IRadimed (IRMD) United States $0.555B 31.07
Pacific Biosciences Of California (PACB) United States $0.523B 0.00
Pulse Biosciences (PLSE) United States $0.474B 0.00
Nevro (NVRO) United States $0.386B 0.00
Tactile Systems Technology (TCMD) United States $0.324B 11.10
Treace Medical Concepts (TMCI) United States $0.306B 0.00
Sight Sciences (SGHT) United States $0.282B 0.00
AxoGen (AXGN) United States $0.271B 0.00
908 Devices (MASS) United States $0.236B 0.00
AngioDynamics (ANGO) United States $0.233B 0.00
EDAP TMS S.A (EDAP) France $0.231B 0.00
NeuroPace (NPCE) United States $0.230B 0.00
Delcath Systems (DCTH) United States $0.223B 0.00
Inogen (INGN) United States $0.207B 0.00
Atossa Genetics (ATOS) United States $0.201B 0.00
Alpha Tau Medical (DRTS) Israel $0.189B 0.00
CVRx (CVRX) United States $0.179B 0.00
ClearPoint Neuro (CLPT) United States $0.168B 0.00
Semler Scientific (SMLR) United States $0.166B 8.42
Accuray (ARAY) United States $0.159B 0.00
Spectral Diagnostics (EDTXF) Canada $0.108B 0.00
Sensus Healthcare (SRTS) United States $0.103B 21.59
KORU Medical Systems (KRMD) United States $0.101B 0.00
Yubo Biotech (YBGJ) China $0.091B 0.00
Neuronetics (STIM) United States $0.076B 0.00
EnVVeno Medical (NVNO) United States $0.067B 0.00
Hyperfine (HYPR) United States $0.065B 0.00
Envoy Medical (COCH) United States $0.064B 0.00
Monogram Orthopaedics (MGRM) United States $0.062B 0.00
InspireMD (NSPR) Israel $0.057B 0.00
Vicarious Surgical (RBOT) United States $0.056B 0.00
SEP Acquisition (SEPA) United States $0.054B 0.00
DarioHealth (DRIO) United States $0.053B 0.00
Lucid Diagnostics (LUCD) United States $0.048B 0.00
LENSAR (LNSR) United States $0.046B 0.00
Autonomix Medical (AMIX) United States $0.043B 0.00
ReWalk Robotics (LFWD) Israel $0.043B 0.00
Precision Optics (POCI) United States $0.040B 0.00
Pixie Dust Technologies (PXDT) Japan $0.036B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
T2 Biosystems (TTOO) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.032B 0.00
Aspira Women's Health (AWH) United States $0.032B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.028B 0.00
Ekso Bionics Holdings (EKSO) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.020B 0.00
Accelerate Diagnostics (AXDX) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.019B 0.00
PAVmed (PAVM) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.014B 0.00
NexGel (NXGL) United States $0.014B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Avinger (AVGR) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00